Elanco Animal Health Inc
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
ELAN$26.76-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in millions, except per-share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $1,265 | $1,137 | $4,004 | $3,571 |
| Cost of sales | 545 | 530 | 1,701 | 1,567 |
| Gross profit | 720 | 607 | 2,303 | 2,004 |
| Research and development | 99 | 89 | 288 | 275 |
| Marketing, selling and administrative | 393 | 351 | 1,223 | 1,092 |
| Amortization of intangible assets | 144 | 140 | 421 | 404 |
| Asset impairment, restructuring and other special charges | 3 | 25 | 28 | 35 |
| Interest expense, net of capitalized interest | 59 | 52 | 175 | 140 |
| Other (income) expense, net | (2) | — | 1 | 23 |
| Income (loss) before income taxes | 24 | (50) | 167 | 35 |
| Income tax expense (benefit) | 6 | (16) | 38 | (9) |
| Net income (loss) | $18 | $(34) | $129 | $44 |
| Earnings (loss) per share: | ||||
| Basic | $0.04 | $(0.07) | $0.26 | $0.09 |
| Diluted | $0.04 | $(0.07) | $0.26 | $0.09 |
| Weighted-average shares outstanding: | ||||
| Basic | 499.7 | 496.8 | 498.9 | 496.2 |
| Diluted | 506.5 | 496.8 | 506.0 | 501.2 |
2026 Q3 Form 10-Q | 4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.